Evidence map›Paper›PMID 25730369›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2015

Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues.

Sibylle Gündisch, Laura Annaratone, Christian Beese, Enken Drecol, Caterina Marchiò, Elena Quaglino, Anna Sapino, Karl-Friedrich Becker, Gianni Bussolati

Open access · hybridAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. The SOS1 Inhibitor BI 1701963 as Monotherapy or in Combination with Trametinib in Patients with KRAS Mutation-Positive Solid Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.Laboratory investigation; a journal of technical methods and pathology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sibylle GündischInstitute of Pathology, Technische Universität München, Trogerstrasse, Munich, Germany.
Laura AnnaratoneDepartment of Medical Sciences, University of Turin, Via Santena, Turin, Italy.
Christian BeeseInstitute of Pathology, Technische Universität München, Trogerstrasse, Munich, Germany.
Enken DrecolInstitute of Pathology, Technische Universität München, Trogerstrasse, Munich, Germany.
Caterina Marchiò1] Department of Medical Sciences, University of Turin, Via Santena, Turin, Italy [2] Pathology Service, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Via Santena, Turin, Italy.
Elena QuaglinoDepartment of Molecular Biotechnologies and Health Sciences, University of Turin, Via Nizza, Turin, Italy.
Anna Sapino1] Department of Medical Sciences, University of Turin, Via Santena, Turin, Italy [2] Pathology Service, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Via Santena, Turin, Italy.
Karl-Friedrich BeckerInstitute of Pathology, Technische Universität München, Trogerstrasse, Munich, Germany.
Gianni BussolatiDepartment of Medical Sciences, University of Turin, Via Santena, Turin, Italy.
University of Turin · ITTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most efficient approach for therapy selection to inhibit the deregulated kinases in cancer tissues is to measure their phosphorylation status prior to the treatment. The aim of our study was to evaluate the influence of pre-analytical parameters (cold ischemia time, temperature before and during tissue fixation, and sample type) on the levels of proteins and phosphoproteins in breast cancer tissues, focusing on the PI3 kinase/AKT pathway. The BALB-neuT mouse breast cancer model expressing HER2 and pAKT proteins and human biopsy and resection specimens were analyzed. By using quantitative reverse phase protein arrays (RPPA), 9 proteins and 16 phosphoproteins relevant to breast cancer biology were assessed. Cold temperatures before and during fixation resulted in a marked improvement in the preservation of the reactivity of biological markers (eg, ER, HER2) in general and, specifically, pHER2 and pAKT. Some phosphoproteins, eg, pHER2 and pAKT, were more sensitive to prolonged cold ischemia times than others (eg, pS6RP and pSTAT5). By comparing the phosphoprotein levels in core needle biopsies with those in resection specimens, we found a marked decrease in many phosphoproteins in the latter. Cold conditions can improve the preservation of proteins and phosphoproteins in breast cancer tissues. Biopsies ≤ 1 mm in size are the preferred sample type for assessing the activity of deregulated kinases for personalized cancer treatments because the phosphoprotein levels are better preserved compared with resection specimens. Each potential new (phospho)protein biomarker should be tested for its sensitivity to pre-analytical processing prior to the development of a diagnostic assay.

Indexed as

AnimalsBiomarkers, TumorBreast NeoplasmsCold IschemiaErb-b2 Receptor Tyrosine KinasesFemaleHumansMaleMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CMice, TransgenicPhosphatidylinositol 3-KinasesPhosphoproteinsProto-Oncogene Proteins c-aktSpecimen HandlingBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesPhosphatidylinositol 3-KinasesPhosphoproteinsProto-Oncogene Proteins c-akt

Identifiers

PMID25730369
PMCPMC4421866
OpenAlexW2032500497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.